DI COSTANZO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.485
EU - Europa 1.304
AS - Asia 277
AF - Africa 2
Totale 3.068
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.482
RU - Federazione Russa 464
PL - Polonia 420
IE - Irlanda 119
IT - Italia 119
SE - Svezia 100
SG - Singapore 71
CN - Cina 67
HK - Hong Kong 55
JO - Giordania 31
IN - India 27
VN - Vietnam 22
DE - Germania 18
AT - Austria 10
GB - Regno Unito 10
FI - Finlandia 8
CH - Svizzera 7
UA - Ucraina 7
ES - Italia 6
FR - Francia 4
KR - Corea 4
NL - Olanda 4
BE - Belgio 3
CA - Canada 3
CI - Costa d'Avorio 2
HR - Croazia 2
DK - Danimarca 1
GR - Grecia 1
LT - Lituania 1
Totale 3.068
Salva come PNG Salva come JPEG
Città #
Warsaw 420
Santa Clara 268
Fairfield 209
Dublin 119
Chandler 116
Seattle 84
Ashburn 83
Woodbridge 77
Cambridge 68
Houston 65
Wilmington 65
Singapore 58
Lawrence 43
Altamura 42
Ann Arbor 41
Hong Kong 36
Princeton 31
Moscow 25
Buffalo 23
Florence 22
Boston 21
Mumbai 20
Beijing 18
Dong Ket 18
Boardman 17
Shanghai 17
New York 16
Medford 12
San Diego 11
Munich 10
Vienna 10
Rome 8
Bern 7
Pune 7
Redwood City 7
Barcelona 6
Los Angeles 6
Norwalk 6
Bremen 4
Falls Church 4
Hillsboro 4
Seoul 4
Yubileyny 4
Brussels 3
Kent 3
Lucca 3
Mykolayiv 3
Shenzhen 3
Toronto 3
Abidjan 2
Amsterdam 2
Cantu 2
Cinisello Balsamo 2
Conversano 2
Guangzhou 2
Hangzhou 2
Jönköping 2
Laurel 2
Milan 2
Nanjing 2
Owings Mills 2
Padova 2
Perugia 2
Phoenix 2
Pietrasanta 2
Pisa 2
Prato 2
Redmond 2
Xian 2
Zagreb 2
Aigaleo 1
Andover 1
Augusta 1
Cagliari 1
Frankfurt am Main 1
Groningen 1
Incisa 1
Jacksonville 1
Kunming 1
London 1
Lyngby 1
Modena 1
Mountain View 1
Naaldwijk 1
Newark 1
Old Bridge 1
Pozzo 1
Robecco 1
Salerno 1
Saronno 1
Siena 1
Southend 1
Subbiano 1
Venezia 1
Vicchio 1
Washington 1
Wuxi 1
Youngstown 1
Totale 2.220
Salva come PNG Salva come JPEG
Nome #
HERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy 260
Gallbladder neuroendocrine neoplasm: a case report and critical evaluation of WHO classification 192
Adjuvant chemotherapy in completely resected gastric cancer: A randomized phase III trial conducted by GOIRC 180
hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma 160
Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study 143
hERG1 and HIF-2α Behave as Biomarkers of Positive Response to Bevacizumab in Metastatic Colorectal Cancer Patients 141
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial 129
Evaluation of RAS mutational status through BEAMing assay to monitor disease progression of metastatic colorectal cancer: a case report 122
Osteonecrosis of the Jaw and Angiogenesis inhibitors: A Revival of a Rare but Serous Side Effect 122
Circulating tumour cells in colorectal cancer 121
Endocrine toxicity in cancer patients treated with nivolumab or pembrolizumab: results of a large multicentre study. 121
KRAS and NRAS mutation detection in circulating DNA from patients with metastatic colorectal cancer using BEAMing assay: Concordance with standard biopsy and clinical evaluation 113
Physical exercise and eating habits in cancer survivors 111
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues 106
Oxaliplatin-Based Chemotherapy in Advanced Neuroendocrine Tumors: Clinical Outcomes and Preliminary Correlation with Biological Factors 102
Effects of a home based exercise rehabilitation program for cancer survivors 101
Regorafenib also can cause osteonecrosis of the jaw 101
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer. 89
Temperament and character traits associated with health-related quality of life in cancer patients 84
Bevacizumab in non-small cell lung cancer 83
A transcriptomic approach reveals selective ribosomal remodelling in the tumour versus the stromal compartment of metastatic colorectal cancer 82
A multi-center study on the surgical management of metastatic disease to adrenal glands 81
Quality of life, compliance, safety and effectiveness in fit older metastatic colorectal patients with cancer treated in first-line with chemotherapy plus cetuximab: A restrospective analysis from the ObservEr study 80
ITACA-S (Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach) Trial: comparison of a sequential treatment with irinotecan (cpt-11) + 5-fluorouracil (5-FU)/folinic acid (LV) followed by docetaxel and cisplatin versus a 5-FU/LV regimen as postoperative treatment for radically resected gastric cancer 76
Phase II trial of single-agent oral vinorelbine in elderly (> or =70 years) patients with advanced non-small-cell lung cancer and poor performance status 66
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme 60
Phase II study of 5-FU plus 6-S-leucovorin (6S-LV) in advanced colorectal cancer 53
Prognostic role of hERG1 Potassium Channels in Neuroendocrine Tumours of the Ileum and Pancreas 49
Totale 3.128
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.719
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.719
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020349 0 0 0 0 45 46 45 51 51 33 69 9
2020/2021540 45 39 21 82 26 53 39 40 53 83 32 27
2021/2022224 8 17 21 8 5 15 5 15 19 13 31 67
2022/2023608 57 131 33 27 38 110 76 36 68 5 15 12
2023/2024225 3 19 28 12 10 50 15 47 2 16 12 11
2024/2025907 45 151 79 285 347 0 0 0 0 0 0 0
Totale 3.128